CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients.
about
Circulating cytotoxic CD8(+) CD28(-) T cells in ankylosing spondylitisIn vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes.Identification of HLA-E-specific alloreactive T lymphocytes: a cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells.KIR2DL2 enhances protective and detrimental HLA class I-mediated immunity in chronic viral infectionImmunologic characteristics of intrarenal T cells: trafficking of expanded CD8+ T cell β-chain clonotypes in progressive lupus nephritis.IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanismHLA-E expression by gynecological cancers restrains tumor-infiltrating CD8⁺ T lymphocytes.Circulating activated and effector memory T cells are associated with calcification and clonal expansions in bicuspid and tricuspid valves of calcific aortic stenosis.Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis.Preferential type 1 chemokine receptors and cytokine production of CD28- T cells in ankylosing spondylitis.Global transcriptional analysis delineates the differential inflammatory response interleukin-15 elicits from cultured human T cellsQa-1 restriction of CD8+ suppressor T cells.Expansion of polyfunctional HIV-specific T cells upon stimulation with mRNA electroporated dendritic cells in the presence of immunomodulatory drugsA critical role for DAP10 and DAP12 in CD8+ T cell-mediated tissue damage in large granular lymphocyte leukemia.Adaptive Memory of Human NK-like CD8+ T-Cells to Aging, and Viral and Tumor Antigens.Divide, Conquer, and Sense: CD8+CD28- T Cells in Perspective.HLA-E expression and its clinical relevance in human renal cell carcinoma.Regulation of NKG2D+CD8+ T-cell-mediated antitumor immune surveillance: Identification of a novel CD28 activation-mediated, STAT3 phosphorylation-dependent mechanism.Antigen-independent acquisition of MHC class II molecules by human T lymphocytes.Expression of killer cell inhibitory receptors is restricted to true NK cell lymphomas and a subset of intestinal enteropathy-type T cell lymphomas with a cytotoxic phenotype.CD8beta/CD28 expression defines functionally distinct populations of peripheral blood T lymphocytes.T cell senescence and contraction of T cell repertoire diversity in patients with chronic obstructive pulmonary disease.Increased expression of non-functional killer inhibitory receptor CD94 in CD8+ cells of myeloma patients.Increased expression of the natural killer cell inhibitory receptor CD85j/ILT2 on antigen-specific effector CD8 T cells and its impact on CD8 T-cell function
P2860
Q24800177-D698BCFA-11A2-4019-A0C0-53FFCE94A9D1Q33178945-AC5E662F-7A2B-4F29-9753-E185E756B972Q34038159-2E92088A-C541-412E-81ED-22D0B645BBFCQ34055276-16D40A24-D6BD-4AA4-9B91-3AF406EE28AEQ34087313-CD0EDCA2-C267-4DB5-BF00-30FBFC3AC497Q34825943-215CCBAD-1460-4F7E-B460-167BCFF850DBQ35081677-48F45467-2FF0-4518-87F0-23933D1CF7FDQ35091286-40D9D7A8-D92B-4BFB-9208-C7D7FBCCFD11Q35234747-D185E556-53AE-441B-B328-9BBA706825E5Q35637105-73817D7E-13FF-4809-B91A-1578BBB660A4Q35758126-D0C2AC0E-254B-4EE0-9A84-192347CC9BF8Q35936489-AD58A2F2-0898-4759-A2C2-B181E9EB85F2Q36154837-1A90AB4D-6223-424D-8EAD-72DC785C2BECQ37151172-5121A324-0FD4-40CA-92D2-04FCEAD0E027Q37513048-748C6D3A-F29A-4721-8CDC-DFC7B3BE063FQ37550716-CBC84166-5A68-4CCA-8F4D-DD092C572369Q39427922-0837B2A9-B228-4686-87E4-75DBB27DF77CQ40357852-83BB6058-5F18-486B-BAEC-EBACDDFFC633Q41752204-EAEEFA6C-1CFD-43C9-B251-2D20BDAB79DAQ42041467-FF39CFB5-289C-4C8A-8629-4916887E64A0Q47675185-1D3EFD0A-D154-4C46-B323-AA6FA636B843Q51818412-F88678C1-0363-4F6A-AB16-6280A1D27AB7Q52026563-08FDB773-E393-4EA6-A72B-87659FA4FB40Q58321593-3DE2C9A5-FACD-4D4A-895B-F5A040D75499
P2860
CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
CD28-negative cytolytic effect ...... donors and melanoma patients.
@ast
CD28-negative cytolytic effect ...... donors and melanoma patients.
@en
type
label
CD28-negative cytolytic effect ...... donors and melanoma patients.
@ast
CD28-negative cytolytic effect ...... donors and melanoma patients.
@en
prefLabel
CD28-negative cytolytic effect ...... donors and melanoma patients.
@ast
CD28-negative cytolytic effect ...... donors and melanoma patients.
@en
P2093
P1476
CD28-negative cytolytic effect ...... donors and melanoma patients.
@en
P2093
Cerottini JC
Cerundolo V
MacDonald HR
Speiser DE
P304
P356
10.1002/(SICI)1521-4141(199906)29:06<1990::AID-IMMU1990>3.3.CO;2-0
P407
P577
1999-06-01T00:00:00Z